Article
CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka.
Pharmacogenomics - 1 Jan 2024
Ranasinghe Priyanga, Gunarathna Pulasthi B, Jeyapragasam Hajanthy, Sirisena Nirmala, Hendalage D P Bhagya, Dissanayake Vajira H W
Abstract excerpt
AIMS: Clopidogrel exhibits substantial variability in therapeutic response, largely contributed by genetic factors. The pharmacogenomic variants data on clopidogrel metabolism in South Asians have been sparsely studied. This study explores the impact of CYP2C19 and CES1 gene variants on clopidogrel metabolism in Sri Lankans, revealing significant pharmacogenomic insights with broader implications for South...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
